Virica Biotech

Jean-Simon Diallo, Ph.D., CEO and Scientific Founder
Ottawa, Canada
Virica Biotech is solving many of the development challenges facing viral medicine developers that are caused by the natural defenses that host cells mount against viruses. These challenges range from affecting how the products are manufactured to how they are used to treat patients. Our core Viral Sensitizer (VSE) technology is a versatile additive small molecule platform that fundamentally alters how cells defend themselves against viral infection. Customized VSE formulations optimize research processes and enhance production. VSEs help bring your treatments to patients on an accelerated timeline.

By using this website you agree to accept our Privacy Policy and Terms & Conditions